Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

Researchers say GLP-1 medicines might be able to help with migraines.

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...

Everyone’s talking about Ozempic, Wegovy and Mounjaro, but behind the TikToks and jaw-dropping selfies are real meds with ...